Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 2
This trial is looking at a blood thinning drug called rivaroxaban to see if it can help women with early breast cancer.
It is for women with oestrogen receptor negative (ER negative) breast cancer who are going to have surgery or chemotherapy.
Recruitment start: 26 April 2016
Recruitment end: 25 July 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr. Cliona Kirwan
Liverpool Cancer Trials Unit
NIHR Clinical Research Network: Cancer
University Hospital of South Manchester (UHSM)
Last reviewed: 6 March 2024
CRUK internal database number: 13457
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
